Evaluation of oral factor Xa inhibitor‐associated extracranial bleeding reversal with andexanet alfa-Reference-Cited by-同舟云学术

Evaluation of oral factor Xa inhibitor‐associated extracranial bleeding reversal with andexanet alfa

Published:2020-08-27 Issue:10 Volume:18 Page:2532-2541
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Nederpelt Charlie J.¹²^ORCID,Naar Leon¹,Sylvester Katelyn W.³^ORCID,Barra Megan E.⁴,Roberts Russel J.⁴,Velmahos George C.¹,Kaafarani Haytham M. A.¹,Rosenthal Martin G.¹,King David R.¹

Affiliation:

1. Division of Trauma, Emergency Surgery and Surgical Critical Care Massachusetts General Hospital Boston MA USA

2. Department of Trauma Surgery Leiden University Medical Center Leiden the Netherlands

3. Department of PharmacyBrigham and Women's Hospital Boston MA USA

4. Department of Pharmacy Massachusetts General Hospital Boston MA USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15031

Reference32 articles.

1. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement

2. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

3. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation

4. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

5. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and rationale for REVERXaL: A real-world study of patients with factor Xa inhibitor–associated major bleeds;Thrombosis Research;2024-08

2. Emergency medicine updates: Lower gastrointestinal bleeding;The American Journal of Emergency Medicine;2024-07

3. Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding;European Journal of Anaesthesiology;2024-04-04

4. Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage;Hospital Pharmacy;2024-02-16

5. The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage;Blood Coagulation & Fibrinolysis;2024-02-12